Temporary suppression of tremor by Remifentanil in a patient with Parkinson's disease during cataract-operation under local anaesthesia;Vorübergehende beseitigung des tremors bei m. Parkinson durch Remifentanil während einer kataraktoperation in lokalanästhesie

Anaesthesist

Volumn 52, Issue 9, 2003, Pages 795-797

  Bohmdorfer W ^a,b   Schwarzinger, Ph ^a   Binder, S ^a   Sporn, P ^a  

^a L Boltzmann Inst Retinol/B L   (Austria)

^b KRANKENANSTALT RUDOLFSTIFTUNG   (Austria)

Author keywords

Opioids; Parkinson's disease; Remifentanil; Sedation; Tremor

Indexed keywords

REMIFENTANIL;

AGED; ARTICLE; CASE REPORT; CATARACT; CLINICAL FEATURE; HUMAN; LOCAL ANESTHESIA; OPERATION DURATION; PARKINSON DISEASE; PULSE OXIMETRY; SEDATION; TREMOR;

AGED; ANESTHESIA, LOCAL; ANESTHETICS, INTRAVENOUS; CATARACT EXTRACTION; FEMALE; HUMANS; INFUSIONS, INTRAVENOUS; PARKINSON DISEASE; PIPERIDINES; TREMOR;

EID: 18744418445     PISSN: 00032417     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00101-003-0522-y     Document Type: Article

References (13)

1. Augustinus (um 400 p.Chr.n.) Confessiones lib.IV cap.5
2. Berg D, Becker G, Reiners K (1999) Reduction of dyskinesia and induction of akinesia induced by morphine in two Parkinsonian patients with severe sciatica. J Neural-Transm 106:725-728
3. Biro P, Abel M, Pasch T (1999) Anästhesie bei seltenen Erkrankungen, 2.Aufl. Springer, Berlin Heidelberg New York, S 327-330
4. Chesselet MF, Cheramy A, Reisine TD, Lubetzki C, Desban M, Glowinski J (1983) Local and distal effects induced by unilateral striatal application of opiates in the absence or in the presence of naloxone on the release of dopamine in both caudate nuclei and substantiae nigrae of the cat. Brain Res 258:229-242
5. Devine DP, Leone P, Pocock D, Wise RA (1993) Differential involvement of ventral tegmental mu, delta and kappa opioid receptors in modulation of basal mesolimbic dopamine release. In: Vivo Microdialysis Studies. J Pharmacol Experiment Therapeutics 266:1236-1246
6. Ferreira JJ, Rascol O (2000) Prevention and therapeutic strategies for levodopa-induced dyskinesias in Parkinson's diseases. Curr Opin Neurol 13:431-436
7. Gilbert JC (1975) Diseases of the central nervous system. Pharmacological basis of treatment. Br Med J 4(5987):33-35
8. th edn. McGraw-Hill, New York, pp 569-619
9. Hanna P,A, Cardoso F, Jankovic J (2001) Basal ganglia and movement disorders. In: Rolak IA (ed) Neurology Secrets. Hanley & Belfus, Philadelphia, pp 147-180
10. Holas A, Krafft P, Marcovic M, Quehenberger F (1999) Remifentanil, propofol or both for conscious sedation during eye surgery under regional anaesthesia. Eur J Anaesthesiol 16:741-748
11. Mets B (1991) Acute dystonia after alfentanil in untreated Parkinson's disease. Anesth Analg 72:557-558
12. Oertel WH, Quinn NP (1996) Movement Disorders Parkinsonism. In: Brandt T, Caplan LR, Dichgans J, Diener HC, Kennard C (eds) Neurological Disorders, Course and Treatment. Academic Press, San Diego, pp 715-755
13. rd edn. Pippincott Williams & Wilkins, Philadelphia, pp 77-113